Search Results

Romidepsin 5 mg  | 99.53%

TargetMol

Romidepsin is an intravenously administered histone deacetylase inhibitor and antineoplastic agent that is approved for use in refractory or relapsed cutaneous and peripheral T cell lymphomas.

More Information Supplier Page

U 19963 50 mg  | 99.40%

TargetMol

U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.

More Information Supplier Page

U 19963 25 mg  | 99.40%

TargetMol

U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.

More Information Supplier Page

U 19963 10 mg  | 99.40%

TargetMol

U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.

More Information Supplier Page

U 19963 100 mg  | 99.40%

TargetMol

U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.

More Information Supplier Page

Temuterkib 5 mg  | Purity Not Available

TargetMol

LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.

More Information Supplier Page

Temuterkib 2 mg  | Purity Not Available

TargetMol

LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.

More Information Supplier Page

Temuterkib 25 mg  | Purity Not Available

TargetMol

LY-3214996 is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity.

More Information Supplier Page

U 19963 5 mg  | 99.40%

TargetMol

U 19963 is an organic compound. It is a potent inhibitor of several enzymes and receptors and has been used to study the effects of drugs on biological systems. It has been found to possess a wide range of biological activities, including anti-inflammatory, anti-tumor and antibacterial properties.

More Information Supplier Page

Autophinib 10 mg  | 98.83%

TargetMol

Autophinib is a potent autophagy inhibitor with a novel chemotype with IC50 values of 90 and 40 nM for autophagy in starvation induced autophagy assay and rapamycin induced autophagy assay.

More Information Supplier Page